Ligand ID: HQE


Drugbank ID:
DB09526
(Hydroquinone)


Indication:
Hydroquinone is used as an OTC topical lightening agent for disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots and freckles.

Get human targets for HQE in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'HQE' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5r84 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.45A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.53A21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
LEU A  30
VAL A  18
LEU A  32
THR A  98
VAL A  36
1.78A21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
GLN A  74
LEU A  89
VAL A  91
VAL A  36
TRP A  31
1.69A21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
GLN A 244
VAL A 247
LEU A 262
THR A 225
THR A 226
1.79A21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.48A23.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6lze VIRAL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.53A23.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.53A22.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.47A22.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m17 RECEPTOR BINDING
DOMAIN
(SARS-CoV-2)		4 / 8
ASP E 364
PHE E 338
LEU E 368
PHE E 515
1.20A20.17
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  20
PHE A  66
LEU A  89
LEU A  87
VAL A  36
1.62A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL B  20
PHE B  66
LEU B  89
LEU B  87
VAL B  36
1.62A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL B 261
LEU B 205
LEU B 242
THR B 243
VAL B 202
1.58A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL D  20
PHE D  66
LEU D  89
LEU D  87
VAL D  36
1.64A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL D 261
LEU D 205
LEU D 242
THR D 243
VAL D 202
1.59A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL D  77
PHE D  66
LEU D  89
VAL D  91
VAL D  36
1.50A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL C 261
LEU C 205
LEU C 242
THR C 243
VAL C 202
1.57A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL C  20
PHE C  66
LEU C  89
LEU C  87
VAL C  36
1.60A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL B  77
PHE B  66
LEU B  89
VAL B  91
VAL B  36
1.47A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.58A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m2q 3CL PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.56A22.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL B 115
VAL A 330
LEU B 103
THR B 124
VAL A 341
1.35A20.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.54A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
THR D  89
THR D  93
1.67A14.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.48A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
NSP7
(SARS-CoV-2)		4 / 8
PHE A 843
LEU A 437
LEU C  40
PHE A 442
1.61A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.48A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 246
VAL A 182
1.38A14.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 286
LEU A 316
PHE A 317
1.30A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP12
(SARS-CoV-2)		5 / 10
PHE A 741
LEU A 723
LEU A 707
THR A 710
VAL A 720
1.57A14.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.53A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 248
THR A 246
1.57A14.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		4 / 8
PRO A 627
PHE A 694
LEU A 786
LEU A 630
1.50A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.51A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		5 / 9
ILE A 201
PRO A 232
PHE A 192
LEU A  90
LEU A 205
1.79A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6m71 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.52A14.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE B 119
PRO A 323
LEU A 270
PHE A 275
1.51A15.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE A 333
PRO A 339
LEU B  95
PHE B  92
1.56A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		4 / 8
ILE A 837
PHE A 419
LEU A 883
PHE A 428
1.56A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 238
LEU A 316
PHE A 313
1.53A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
LEU D  95
THR D  93
1.58A14.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6m71 NSP12
(SARS-CoV-2)		4 / 8
ILE A 244
LEU A 247
TYR A 175
PHE A 134
1.46A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 9
ILE A 434
PRO A 384
LEU A 368
LEU A 387
PHE A 515
1.78A16.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ASP C 979
PHE B 565
LEU B 546
LEU B 518
1.19A16.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_D_HQED503_1
(CATALASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 9
ILE A 434
PRO A 384
LEU A 368
LEU A 387
PHE A 515
1.79A16.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6vxs NSP3
(SARS-CoV-2)		6 / 10
GLN B 118
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6vxs NSP3
(SARS-CoV-2)		6 / 10
GLN A 118
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6vxs NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE C 666
PRO A 862
LEU C 611
LEU A 861
1.22A15.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE C 666
PRO A 862
LEU C 611
LEU A 861
1.20A15.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w02 NSP3
(SARS-CoV-2)		6 / 10
GLN B 118
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.63A23.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 8
PRO C 384
LEU C 513
LEU C 387
PHE C 392
1.70A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 8
ILE C 358
PHE C 342
TYR C 365
LEU C 513
1.77A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 8
PHE C 515
LEU C 387
LEU C 513
PHE C 338
1.37A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 8
ILE C 434
PRO C 384
LEU C 368
LEU C 387
1.57A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 8
ILE A6925
PHE A6985
LEU A6959
LEU A6981
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w6y NSP3
(SARS-CoV-2)		5 / 10
GLN B 118
LEU B  93
LEU B 122
THR B 149
VAL B  36
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w6y NSP3
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.70A
None
None
None
AMP  A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.71A
None
None
None
AMP  A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.68A
None
None
None
MES  B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.67A
None
None
None
MES  B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w6y NSP3
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B  93
LEU B 127
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w6y NSP3
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B 127
LEU B 153
1.73A16.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w6y NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  93
VAL A  36
THR A 149
VAL A  34
1.79A24.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
None
None
MES  B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w6y NSP3
(SARS-CoV-2)		5 / 10
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
None
None
AMP  A 201 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w6y NSP3
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6w6y NSP3
(SARS-CoV-2)		6 / 10
GLN A 118
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w75 NSP16
(SARS-CoV-2)		4 / 8
ILE A6925
PHE A6985
LEU A6959
LEU A6981
1.39A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6w75 NSP16
(SARS-CoV-2)		4 / 8
ILE C6925
PHE C6985
LEU C6959
LEU C6981
1.41A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  60
VAL B  11
ALA B  68
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  15
VAL B  66
ALA B  68
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS C  17
ASN C  60
VAL C  11
ALA C  68
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  15
VAL B  66
ALA B  68
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  60
VAL B  11
ALA B  68
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  15
VAL B  66
ALA B  68
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS B  17
ASN B  60
VAL B  11
ALA B  68
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
HIS C  17
ASN C  60
VAL C  11
ALA C  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wcf NSP3
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.68A
None
None
None
MES  A 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
None
None
MES  A 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
None
None
MES  A 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wcf NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wen NSP3
(SARS-CoV-2)		6 / 10
GLN A 118
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wen NSP3
(SARS-CoV-2)		4 / 8
PRO A 136
LEU A 109
TYR A 113
LEU A 126
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wen NSP3
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wen NSP3
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 298
ASN A 241
ALA A 293
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 249
ASN A 241
HIS A 298
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wey NSP3
(SARS-CoV-2)		6 / 10
GLN A 322
LEU A 297
VAL A 299
LEU A 326
THR A 353
VAL A 240
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 298
ASN A 241
ALA A 293
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 249
ASN A 241
HIS A 298
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 298
HIS A 249
ASN A 258
ALA A 242
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 298
HIS A 249
ASN A 258
ALA A 242
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 298
ASN A 241
ALA A 293
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 298
HIS A 249
ASN A 258
ALA A 242
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wey NSP3
(SARS-CoV-2)		4 / 8
PRO A 329
PHE A 320
LEU A 297
LEU A 331
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wey NSP3
(SARS-CoV-2)		4 / 7
HIS A 290
HIS A 249
ASN A 241
HIS A 298
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL A  12
LEU A  13
VAL A  16
LEU B  95
THR B  93
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE E 351
PHE E 346
LEU E 339
PHE E 307
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE C 351
PHE C 346
LEU C 339
PHE C 307
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE B 351
PHE B 346
LEU B 339
PHE B 307
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE F 351
PHE F 346
LEU F 339
PHE F 307
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE D 351
PHE D 346
LEU D 339
PHE D 307
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
ILE A 351
PHE A 346
LEU A 339
PHE A 307
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
HIS A6917
HIS C6917
VAL C7087
ALA C6919
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_B_HQEB303_1
(TYROSINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 5
HIS A6917
HIS C6917
VAL C7087
ALA C6919
1.53A21.17
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
HIS A6917
HIS C6917
VAL C7087
ALA C6919
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 8
ILE A6925
PHE A6985
LEU A6959
LEU A6981
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
HIS A6917
HIS C6917
VAL C7087
ALA C6919
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 8
ILE C6925
PHE C6985
LEU C6959
LEU C6981
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
PRO A 168
PHE A  66
LEU A  56
LEU A 167
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
PRO D 168
PHE D  66
LEU D  56
LEU D 167
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
PRO B 168
PHE B  66
LEU B  56
LEU B 167
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 8
PRO C 168
PHE C  66
LEU C  56
LEU C 167
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkq NSP16
(SARS-CoV-2)		4 / 8
ILE C6925
PHE C6985
LEU C6959
LEU C6981
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wkq NSP16
(SARS-CoV-2)		4 / 8
ILE A6925
PHE A6985
LEU A6959
LEU A6981
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 8
PRO B  68
LEU B  76
TYR B 325
PHE B 195
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 8
ILE A 223
LEU A 228
LEU A 300
PHE A 303
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 8
ILE B 223
LEU B 228
LEU B 300
PHE B 303
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 8
PRO A  68
LEU A  76
TYR A 325
PHE A 195
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.67A
None
None
None
APR  D 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.65A
None
None
None
APR  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
PRO D 125
PHE D 116
LEU D  93
LEU D 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 10
GLN C 118
LEU C  93
VAL C  95
LEU C 122
THR C 149
VAL C  36
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 10
GLN A 118
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
None
None
APR  B 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		6 / 10
GLN B 118
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.67A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.68A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.64A
None
None
None
APR  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.65A
None
None
None
APR  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
PRO C 125
PHE C 116
LEU C  93
LEU C 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.66A
None
None
None
APR  D 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.66A
None
None
None
APR  D 201 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
PHE A   6
LEU A 123
VAL A  34
THR A 149
VAL A  36
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B  93
LEU B 127
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
PHE C   6
LEU C 123
VAL C  34
THR C 149
VAL C  36
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
PHE D   6
LEU D 123
VAL D  34
THR D 149
VAL D  36
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.68A
None
None
None
APR  B 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.69A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
None
None
APR  B 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 8
ILE A6925
PHE A6985
LEU A6959
LEU A6981
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 8
ILE A  68
PHE B  92
LEU A  71
LEU A  59
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
LEU D  95
THR D  93
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL A  12
LEU A  13
VAL A  16
LEU B  95
THR B  93
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
GLN B  88
VAL A  16
VAL A  12
LEU C  40
VAL C  11
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 8
ILE B 106
PHE B  92
LEU A  56
LEU A  71
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 8
ILE D 106
PHE D  92
LEU C  56
LEU C  71
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 7
HIS A  17
ASN A  60
VAL A  11
ALA A  68
1.48A
 CL  A 506 ( 4.7A)
None
CL  A 506 (-3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 7
HIS A  17
ASN A  60
VAL A  11
ALA A  68
1.42A
 CL  A 506 ( 4.7A)
None
CL  A 506 (-3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 7
HIS A  17
ASN A  60
VAL A  11
ALA A  68
1.47A
 CL  A 506 ( 4.7A)
None
CL  A 506 (-3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6xez NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL B 115
VAL A 330
LEU B 103
THR B 124
VAL A 341
1.32A21.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.53A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
LEU A  30
VAL A  18
LEU A  32
THR A  98
VAL A  36
1.77A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
GLN A  74
LEU A  89
VAL A  91
VAL A  36
TRP A  31
1.70A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 8
ILE B 106
PHE B  92
LEU A  60
LEU A  71
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 10
VAL A  12
LEU A  13
VAL A  16
LEU B  95
THR B  93
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 8
ILE A  68
PHE B  92
LEU A  71
LEU A  60
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 10
GLN B  88
VAL A  16
VAL A  12
LEU C  40
VAL C  11
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 8
ILE D 106
PHE D  92
LEU C  56
LEU C  71
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 8
ILE B 106
PHE B  92
LEU A  56
LEU A  71
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
LEU D  95
THR D  93
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PHE E 515
LEU E 387
LEU E 513
PHE E 338
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PRO E 384
LEU E 513
LEU E 387
PHE E 392
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE E 434
PRO E 384
LEU E 368
LEU E 387
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PHE A 515
LEU A 387
LEU A 513
PHE A 338
1.33A
None
DMS  A 905 ( 4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE A 434
PRO A 384
LEU A 368
LEU A 387
1.49A
None
None
None
DMS  A 905 ( 4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE E 434
PRO E 384
LEU E 368
LEU E 387
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PHE E 515
LEU E 387
LEU E 513
PHE E 338
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PRO E 384
LEU E 513
LEU E 387
PHE E 392
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PRO E 384
LEU E 513
LEU E 387
PHE E 392
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PHE E 515
LEU E 387
LEU E 513
PHE E 338
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE E 434
PRO E 384
LEU E 368
LEU E 387
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
ILE A 434
PRO A 384
LEU A 368
LEU A 387
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PRO A 384
LEU A 513
LEU A 387
PHE A 392
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 8
PHE A 515
LEU A 387
LEU A 513
PHE A 338
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
GLN A  74
LEU A  89
VAL A  91
VAL A  36
TRP A  31
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.51A
None
None
None
None
PEG  A 405 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
None
None
EDO  A 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.69A
None
None
None
EPE  E 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.41A
None
None
None
EDO  A 202 ( 4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B  93
LEU B 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.62A
None
None
None
EDO  A 203 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.70A
None
None
None
EDO  D 205 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU E  93
VAL E  95
LEU E 122
THR E 149
VAL E  36
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.71A
None
None
None
EPE  E 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
PHE D   6
LEU D 123
VAL D  34
THR D 149
VAL D  36
1.71A
None
None
None
EDO  D 203 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C  93
VAL C  95
LEU C 122
THR C 149
VAL C  36
1.59A
None
None
None
EDO  C 206 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.70A
None
None
None
EPE  E 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN B 118
LEU B  93
LEU B 122
THR B 149
VAL B  36
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D  93
VAL D  95
LEU D 122
THR D 149
VAL D  36
1.60A
None
None
None
EDO  D 203 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.71A
None
None
None
EDO  D 205 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN C 118
LEU C  93
LEU C 122
THR C 149
VAL C  36
1.63A
None
None
None
EDO  C 206 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO C 125
PHE C 116
LEU C  93
LEU C 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN D 118
LEU D  93
LEU D 122
THR D 149
VAL D  36
1.64A
EDO  D 201 ( 4.4A)
None
None
EDO  D 203 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN A 118
LEU A  93
LEU A 122
THR A 149
VAL A  36
1.63A
EDO  D 201 ( 4.5A)
None
None
EDO  A 203 ( 4.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO D 136
LEU D 109
TYR D 113
LEU D 126
1.61A
None
EDO  D 204 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.70A
None
None
None
EDO  A 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO D 125
PHE D 116
LEU D  93
LEU D 127
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.69A
None
None
None
EDO  D 205 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.71A
None
None
None
EDO  A 202 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN E 118
LEU E  93
LEU E 122
THR E 149
VAL E  36
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO E 125
PHE E 116
LEU E  93
LEU E 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.70A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO E 125
PHE E 116
LEU E  93
LEU E 127
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
None
None
APR  B 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.70A
None
None
None
APR  A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.69A
None
None
None
APR  E 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO D 136
LEU D 109
TYR D 113
LEU D 126
1.62A
None
None
None
APR  D 201 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D  93
VAL D  95
LEU D 122
THR D 149
VAL D  36
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.70A
None
None
None
APR  D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO D 125
PHE D 116
LEU D  93
LEU D 127
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
None
None
APR  B 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
None
None
APR  B 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  45
ASN D  37
HIS D  94
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.68A
None
None
None
APR  D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  86
HIS D  94
ASN D  37
ALA D  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.69A
None
None
None
APR  E 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B  93
LEU B 127
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C  93
VAL C  95
LEU C 122
THR C 149
VAL C  36
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN A 118
LEU A  93
LEU A 122
THR A 149
VAL A  36
1.60A
EDO  D 203 (-3.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.68A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  94
HIS E  45
ASN E  54
ALA E  38
1.70A
None
None
None
APR  E 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN E 118
LEU E  93
LEU E 122
THR E 149
VAL E  36
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.71A
None
None
None
APR  A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN D 118
LEU D  93
LEU D 122
THR D 149
VAL D  36
1.59A
EDO  A 207 ( 4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO C 125
PHE C 116
LEU C  93
LEU C 127
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  45
ASN E  37
HIS E  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS E  86
HIS E  94
ASN E  37
ALA E  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		6 / 10
GLN B 118
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.69A
None
None
None
APR  C 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS D  94
HIS D  45
ASN D  54
ALA D  38
1.69A
None
None
None
APR  D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.70A
None
None
None
APR  A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN C 118
LEU C  93
LEU C 122
THR C 149
VAL C  36
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU E  93
VAL E  95
LEU E 122
THR E 149
VAL E  36
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.68A
None
None
None
MES  C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.69A
None
None
None
MES  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  59
HIS A  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  59
HIS A  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.69A
None
None
None
MES  C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  59
HIS A  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.70A
None
None
None
MES  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C  93
VAL C  95
LEU C 122
THR C 149
VAL C  36
1.61A
None
None
None
EDO  C 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  45
ASN B  37
HIS B  94
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO C 125
PHE C 116
LEU C  93
LEU C 127
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO B 125
PHE B 116
LEU B  93
LEU B 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  45
ASN A  37
HIS A  94
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  94
HIS C  45
ASN C  54
ALA C  38
1.70A
None
None
None
MES  C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  45
ASN C  37
HIS C  94
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  86
HIS A  94
ASN A  37
ALA A  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		6 / 10
GLN B 118
LEU B  93
VAL B  95
LEU B 122
THR B 149
VAL B  36
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  86
HIS B  94
ASN B  37
ALA B  89
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A  93
VAL A  95
LEU A 122
THR A 149
VAL A  36
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS A  94
HIS A  45
ASN A  54
ALA A  38
1.68A
None
None
None
MES  A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN A 118
LEU A  93
LEU A 122
THR A 149
VAL A  36
1.63A
EDO  A 202 (-4.6A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS B  94
HIS B  45
ASN B  54
ALA B  38
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO B 136
LEU B 109
TYR B 113
LEU B 126
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
PRO A 125
PHE A 116
LEU A  93
LEU A 127
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
HIS C  86
HIS C  94
ASN C  37
ALA C  89
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
GLN C 118
LEU C  93
LEU C 122
THR C 149
VAL C  36
1.62A
EDO  A 204 (-4.1A)
None
None
EDO  C 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bqy MAIN PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
ILE A 837
PHE A 419
LEU A 838
LEU A 883
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.64A
 ZN  A1002 (-3.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
LEU D  95
THR D  93
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE B 119
PRO A 323
LEU A 270
PHE A 275
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 286
LEU A 316
PHE A 317
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
ILE A  66
PHE A  70
TYR A  69
LEU A  19
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE A 539
PRO A 328
LEU A 673
LEU B 117
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL A 330
LEU B 117
VAL B 115
THR B 123
THR B 124
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
PRO A 627
PHE A 694
LEU A 786
LEU A 630
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL B 115
VAL A 330
LEU B 103
THR B 124
VAL A 341
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP12
(SARS-CoV-2)		5 / 10
PHE A 741
LEU A 723
LEU A 707
THR A 710
VAL A 720
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE A 333
PRO A 339
LEU B  95
PHE B  92
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.63A
 ZN  A1002 (-3.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_B_HQEB503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		5 / 9
ILE A 201
PRO A 232
PHE A 192
LEU A 205
ASP A 218
1.74A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 238
LEU A 316
PHE A 313
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 246
VAL A 182
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7btf NSP8
(SARS-CoV-2)		5 / 10
VAL D 167
LEU D 184
VAL D 159
THR D 145
VAL D 186
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		5 / 9
ILE A 201
PRO A 232
PHE A 192
LEU A 205
ASP A 218
1.72A19.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.63A
 ZN  A1002 (-3.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		4 / 8
ILE A 244
LEU A 247
TYR A 175
PHE A 134
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7btf NSP12
(SARS-CoV-2)		5 / 8
ILE A 201
PRO A 232
PHE A 192
LEU A  90
LEU A 205
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7btf NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 10
VAL A 261
LEU A 205
LEU A 242
THR A 243
VAL A 202
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  77
PHE A  66
LEU A  89
VAL A  91
VAL A  36
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		5 / 10
VAL A  20
PHE A  66
LEU A  89
LEU A  87
VAL A  36
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE A 333
PRO A 339
LEU B  95
PHE B  92
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_B_HQEB503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 9
ILE A 201
PRO A 232
PHE A 192
LEU A  90
LEU A 205
1.76A19.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 9
ILE A 201
PRO A 232
PHE A 192
LEU A  90
LEU A 205
1.74A19.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.63A
 ZN  A1002 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.61A
 ZN  A1002 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.61A
 ZN  A1002 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP7
NSP8
(SARS-CoV-2)		5 / 10
VAL C  12
LEU C  13
VAL C  16
LEU D  95
THR D  93
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP12
(SARS-CoV-2)		5 / 10
PHE A 741
LEU A 723
LEU A 707
THR A 710
VAL A 720
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL A 330
LEU B 117
VAL B 115
THR B 123
THR B 124
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 8
ILE A 539
PRO A 328
LEU A 673
LEU B 117
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 8
PRO A 627
PHE A 694
LEU A 786
LEU A 630
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL B 115
VAL A 330
LEU B 103
THR B 124
VAL A 341
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 8
ILE A 201
PRO A 232
PHE A 192
LEU A  90
LEU A 205
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 8
ASP A 833
PRO A 832
LEU A 838
LEU A 869
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 286
LEU A 316
PHE A 317
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 246
VAL A 182
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv1 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 248
THR A 246
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 8
ILE A 244
LEU A 247
TYR A 175
PHE A 134
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 238
LEU A 316
PHE A 313
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 8
ASP A 336
PHE A 340
LEU A 366
PHE B  92
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 8
ILE A 244
LEU A 247
TYR A 175
PHE A 134
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.56A
 ZN  A1002 (-3.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
NSP7
(SARS-CoV-2)		4 / 8
PHE A 843
LEU A 437
LEU C  40
PHE A 442
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv2 NSP12
(SARS-CoV-2)		5 / 10
PHE A 741
LEU A 723
LEU A 707
THR A 710
VAL A 720
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv2 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 248
THR A 246
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 8
LEU A 186
TYR A 238
LEU A 316
PHE A 313
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL A 330
LEU B 117
VAL B 115
THR B 123
THR B 124
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 8
ILE A 201
PRO A 232
LEU A  90
LEU A 205
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 8
ILE A 837
PHE A 419
LEU A 883
PHE A 428
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv2 NSP12
(SARS-CoV-2)		5 / 10
PHE A 287
LEU A 186
LEU A 245
THR A 246
VAL A 182
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E3H_A_HQEA303_1
(CARBONIC ANHYDRASE 2)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 10
VAL B 115
VAL A 330
LEU B 103
THR B 124
VAL A 341
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 8
PRO A 627
PHE A 694
LEU A 786
LEU A 630
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_B_HQEB304_1
(TYROSINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.54A
 ZN  A1002 (-3.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3A_A_HQEA303_1
(TYROSINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
HIS A 642
ASN A 568
HIS A 572
ALA A 639
1.54A
 ZN  A1002 (-3.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3B_A_HQEA303_1
(TYROSINASE)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
HIS A  99
ASN A 209
VAL A  96
ALA A  97
1.70A
None